pSIRV-NFAT-eGFP Citations (8)

Originally described in: Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-kappaB, NFAT and AP-1.
Jutz S, Leitner J, Schmetterer K, Doel-Perez I, Majdic O, Grabmeier-Pfistershammer K, Paster W, Huppa JB, Steinberger P J Immunol Methods. 2016 Jan 15. pii: S0022-1759(16)30007-2. doi: 10.1016/j.jim.2016.01.007. PubMed Journal

---

Articles Citing pSIRV-NFAT-eGFP

Articles
In vitro and ex vivo functional characterization of human HLA-DRB1 *04 restricted T cell receptors. Boddul SV, Sharma RK, Dubnovitsky A, Raposo B, Gerstner C, Shen Y, Iyer VS, Kasza Z, Kwok WW, Winkler AR, Klareskog L, Malmstrom V, Bettini M, Wermeling F. J Transl Autoimmun. 2021 Mar 3;4:100087. doi: 10.1016/j.jtauto.2021.100087. eCollection 2021. PubMed
SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models. Hyrenius-Wittsten A, Su Y, Park M, Garcia JM, Alavi J, Perry N, Montgomery G, Liu B, Roybal KT. Sci Transl Med. 2021 Apr 28;13(591). pii: 13/591/eabd8836. doi: 10.1126/scitranslmed.abd8836. PubMed
TRAF6 prevents fatal inflammation by homeostatic suppression of MALT1 protease. O'Neill TJ, Seeholzer T, Gewies A, Gehring T, Giesert F, Hamp I, Grass C, Schmidt H, Kriegsmann K, Tofaute MJ, Demski K, Poth T, Rosenbaum M, Schnalzger T, Ruland J, Gottlicher M, Kriegsmann M, Naumann R, Heissmeyer V, Plettenburg O, Wurst W, Krappmann D. Sci Immunol. 2021 Nov 12;6(65):eabh2095. doi: 10.1126/sciimmunol.abh2095. Epub 2021 Nov 12. PubMed
Sense-and-Respond Payload Delivery Using a Novel Antigen-Inducible Promoter Improves Suboptimal CAR-T Activation. Guo T, Ma D, Lu TK. ACS Synth Biol. 2022 Apr 15;11(4):1440-1453. doi: 10.1021/acssynbio.1c00236. Epub 2022 Mar 22. PubMed
Conditional control of universal CAR T cells by cleavable OFF-switch adaptors. Kvorjak M, Ruffo E, Tivon Y, So V, Parikh AB, Deiters A, Lohmueller J. bioRxiv. 2023 May 23:2023.05.22.541664. doi: 10.1101/2023.05.22.541664. Preprint. PubMed
A Reappraisal of the Effects of L-type Ca(2+) Channel Blockers on Store-Operated Ca(2+) Entry and Heart Failure. Bird GS, D'Agostin D, Alsanosi S, Lip S, Padmanabhan S, Parekh AB. Function (Oxf). 2023 Oct 12;4(6):zqad047. doi: 10.1093/function/zqad047. eCollection 2023. PubMed
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16. Casey NP, Kleinmanns K, Forcados C, Gelebart PF, Joaquina S, Lode M, Benard E, Kaveh F, Caulier B, Helgestad Gjerde C, Garcia de Jalon E, Warren DJ, Lindemann K, Rokkones E, Davidson B, Myhre MR, Kvalheim G, Bjorge L, McCormack E, Inderberg EM, Walchli S. J Immunother Cancer. 2024 Apr 11;12(4):e008179. doi: 10.1136/jitc-2023-008179. PubMed
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia. Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, Gjerstad ME, Floisand Y, Kvalheim G, Marr C, Kobold S, Enserink JM, Gjertsen BT, McCormack E, Inderberg EM, Walchli S. Cell Rep Med. 2024 Jun 18;5(6):101572. doi: 10.1016/j.xcrm.2024.101572. Epub 2024 May 15. PubMed

If you have published an article using this material, please email us at to have your article added to this page.